Status and phase
Conditions
Treatments
About
The main purpose of this study is to explore if the combination of autologous NK cell infusion and chemotherapy can increase the therapeutic efficiency in the treatment of non-small cell lung cancer compared with chemotherapy alone.
Full description
Natural killer cells play an important role in the anti-tumor process mediated by innate immunity. However, past researches showed dissatisfactory clinical outcome in clinicaltrials using autologous NK cell infusion alone. With the expectation that the combination of autologous NK cell infusion and chemotherapy may increase the therapeutic efficiency of chemotherapy alone in cancer treatment, the investigators design and conduct this randomized controlled trial in the treatment of non-small cell lung cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Subjects meeting any of the following criteria are not eligible for participation in the study:
Primary purpose
Allocation
Interventional model
Masking
104 participants in 2 patient groups
Loading...
Central trial contact
Cheng Qian, MD, PhD; Zhi Yang, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal